Search For "gilead"
Antiviral drug -- Remdesivir -- is next big thing in fight against COVID-1
Updated : 6 years ago IST
New Delhi [India], May 2 (ANI): Since the onset of global coronavirus pandemic, scientists, experts and medical practitioners are vigorously engaged in researching for the most effective treatment of COVID-19 patients. As per the experts, antiviral drug -- Remdesivir -- could be the answe
Read More
Gilead's anti-viral remdesivir gets FDA emergency use authorisation for tr
Updated : 6 years ago IST
California [USA], May 2 (ANI): US-based biopharmaceutical major Gilead Sciences said that the US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) for investigational anti-viral remdesivir to treat COVID-19.
Read More
ICMR conducting observational study on HCQ: Ganagakhedkar
Updated : 6 years, 1 month ago IST
New Delhi [India], April 18 (ANI): The Indian Council of Medical Research (ICMR) on Saturday said it is conducting "observational study" on hydroxychloroquine (HCQ).
Read More
Here's bone-chilling first trailer of 'The Handmaid`s Tale' season 2
Updated : 8 years, 4 months ago IST
New Delhi [India], Jan 15 (ANI): Get ready to witness life outside the confines of Gilead as the first-look trailer for the second season of 'The Handmaid's Tale' has arrived.
Read More
John Chambers-led USIBC delegation to Vibrant Gujarat Summit among the lar
Updated : 8 years, 9 months ago IST
New Delhi [India], Jan 9 (ANI): John Chambers, USIBC Board Chairman and Executive Chairman, Cisco Systems will lead a delegation of almost 100 representatives from leading US companies to the 8th Vibrant Gujarat Summit. Several other USIBC member companies including Cisco, Emerson, CME Group
Read More
Tata Trusts, Gilead sign MoU on viral hepatitis in India
Updated : 8 years, 9 months ago IST
New Delhi, Aug 8 (ANI): Tata Trusts has announced signing of an agreement with the US-headquartered biopharmaceutical company Gilead Sciences to explore collaboration to tackle the viral hepatitis in the country, a release stated.
Read More
Tata Trusts, Gilead sign MoU to address viral hepatitis in India
Updated : 8 years, 9 months ago IST
New Delhi, Aug 4 (ANI): Tata Trusts and Gilead Sciences, Inc. today signed a Memorandum of Understanding (MoU) under the presence of Chairman Tata Trusts, Ratan Tata to explore collaborating within India on an initiative to address the burden of viral hepatitis in the country.
Read More